T. Daniel Logan's Promotion Marks a New Era for KKB Law Firm

Kleinfeld Kaplan & Becker LLP Welcomes New Partner

In an exciting development for the legal community, Kleinfeld Kaplan & Becker LLP (KKB) has announced the election of T. Daniel "Dan" Logan as a partner in the firm. This change marks the beginning of a promising chapter for KKB as they continue to build a formidable team in the regulatory landscape. Mr. Logan officially steps into his new role effective January 1, 2025.

Professional Background and Expertise of Dan Logan

Mr. Logan has cultivated a robust practice specializing in regulatory compliance and advertising law, particularly in the food, cosmetic, drug, dietary supplement, and tobacco industries. His extensive knowledge, gained through years of dedicated service, positions him uniquely within the firm and the broader legal community.

Experience at the FDA

Prior to his tenure at KKB, Dan served as Associate Chief Counsel at the U.S. Food and Drug Administration (FDA). In this role, he provided legal guidance to subject matter experts and developed legal interpretations that fostered the FDA's regulatory objectives. His profound understanding of the intricacies of FDA regulations serves as a significant asset to KKB.

Contributions Beyond Legal Practice

While at the FDA, Mr. Logan was instrumental in various capacities including directing rulemakings and program development at the Center for Tobacco Products. His expertise also extends to overseeing investigations carried out by the Government Accountability Office and the Office of Inspector General of the Department of Health and Human Services.

Celebrating the Promotion's Impact

Will Woodlee, managing partner of KKB, expressed enthusiastic support for Mr. Logan's promotion. He remarked, "Dan’s broad range of skills, diverse experiences, and deep client relationships position him exceptionally well for making significant contributions to the partnership and the broader FDA bar for many years. His promotion will further strengthen our firm’s position among the most comprehensive FDA regulatory and advertising practices in the country.”

Educational Background

Mr. Logan earned his Juris Doctor (cum laude) from the Indiana University Maurer School of Law. He is an active member of the District of Columbia and Maryland bars, underscoring his commitment to legal excellence.

A Firm with a Legacy

Kleinfeld Kaplan & Becker LLP is not just any law firm; it has a rich history of over 60 years in navigating the complex legal waters of food and drug and advertising law. This Washington, DC-based boutique firm continuously addresses the myriad regulations imposed by the FDA on food, drugs and biologics, cosmetics, medical devices, dietary supplements, and tobacco products, among others. Their expertise extends to the realm of controlled substances, unfair trade practice investigations, and compliance issues related to Medicare and Medicaid.

Client-Centered Approach

The firm's client-centric philosophy is evident in the way they engage with consumer products and services regulations. Their deep understanding of the law enables them to offer tailored advice that aligns with their clients' unique needs.

Looking Ahead

KKB's future looks brighter with the addition of Dan Logan to the partnership. His wealth of experience and dedication will undoubtedly enhance their capability in providing quality legal services. As the firm evolves, they remain steadfast in their commitment to excellence, innovation, and client success.

Frequently Asked Questions

Who is T. Daniel Logan?

T. Daniel Logan is a newly elected partner at Kleinfeld Kaplan & Becker LLP known for his expertise in FDA regulatory compliance and advertising law.

When does Dan Logan officially become a partner?

Dan Logan's partnership at KKB takes effect on January 1, 2025.

What is KKB's area of focus?

KKB specializes in legal issues surrounding FDA regulations, including food, drug, and advertising law.

What notable roles did Logan have prior to joining KKB?

Before joining KKB, Logan was an Associate Chief Counsel at the FDA, advising on regulatory compliance and other legal matters.

How can clients contact Dan Logan?

Clients can reach Dan Logan at (202) 223-5120 or via email.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.